Header image

Oral Abstracts - Concurrent 3: Understanding the Epidemics (Modelling/Surveillance)

Tracks
.
Thursday, August 10, 2017
2:00 PM - 3:30 PM
Tully Room I

Speaker

Agenda Item Image
Dr Behzad Hajarizadeh
Associate Professor
Unsw / Kirby Institute

Incidence Of Hepatitis C Virus Infection In Two Maximum-Security Prisons In New South Wales, Australia: The Stop-C Study

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

Behzad Hajari is an epidemiologist, a Lecturer in the Kirby Institute, UNSW and an NHMRC fellow. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. Research interests include natural history of HCV infection, and HCV care in prison setting and among people who inject drugs.
Dr Jenny Iversen
Senior Research Fellow
The Kirby Institute

Progress towards Elimination: Rapid Uptake of HCV Treatment among People Who Inject Drugs Following Broad Access to DAA Therapies

2:15 PM - 2:30 PM

Abstract

Biography

Jenny holds an NHMRC Early Career Fellowship. She has worked in the harm reduction sector since the early 1990s, previously as a health service manager and as a policy analyst. Jenny oversees coordination of surveillance projects within the viral hepatitis epidemiology and prevention program at the Kirby Institute.
Dr Amy Kwon
Research Associate
Kirby Institute, UNSW Sydney

Australia Could Meet The WHO HCV Elimination Targets If The Current Rollout Of DAA Treatment Is Continued’

2:30 PM - 2:45 PM

Abstract

Speaker Presentation

Biography

Amy Kwon has previously been working on understanding the epidemiology of HIV and HCV among people who inject drugs in Australia and assessing the cost-effectiveness of prevention programs. She is currently working on the BRISE HCV and HBV estimates and projections project.
Dr Nick Scott
Econometrician
Burnet Institute

Recommendations For Hepatitis C Virus Testing Among People Who Inject Drugs In Australia

2:45 PM - 3:00 PM

Abstract

Speaker Presentation

Biography

Dr Nick Scott is an Econometrician at the Burnet Institute in Melbourne. He uses mathematical and economic models to inform policy in order to improve the health of vulnerable populations.
Ms Kelly Hosking
Director of Sexual Health Blood Borne Viruses
NT Health & Menzies School of Health Research

Tracking In Arnhem Land – On the Hunt for Hepatitis B Virus

3:00 PM - 3:15 PM

Abstract

Speaker Presentation

Biography

Kelly Hosking is a Public Health Nurse who has spent the last 7 years working in Indigenous Health in the Northern Territory and Torres Strait. Before returning to Australia she worked as an aid worker on public health and HIV programs in Laos, Indonesia and Fiji.
Ms Maryam Alavi
Research Associate
Kirby Institute, UNSW Sydney

Characterisation of Populations with Hepatitis C to Improve Access to Antiviral Therapy Programs: A Population-Based Linkage Study

3:15 PM - 3:20 PM

Abstract

Speaker Presentation

Biography

Maryam’s training and research is based in the field of epidemiology, with a focus on clinical epidemiology. She has a BSc in Biology and a MSc in Clinical Epidemiology. Maryam has completed her PhD in Epidemiology at the University of New South Wales, where she now is a Research Associate.
Dr Karen McCulloch
Research Fellow
University Of Melbourne

Updating Estimates Describing the Burden of Hepatitis B in Australia

3:20 PM - 3:30 PM

Abstract

Speaker Presentation

Biography

Karen's research background and interests are in mathematical modelling of infectious diseases with a particular focus on applications to public health.

Chair

Rachel Sacks-Davis
Research Fellow
Burnet Institute

Agenda Item Image
Linda Selvey
Associate Professor
School Of Public Health, The University Of Queensland





loading